Silverarc Capital Management’s Zura Bio ZURA Stock Holding History

Silverarc Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-560,651	Closed	-$3.34M	–	94
2026 Q1	$3.34M	Buy	+560,651	New	+$3.39M	0.34%	49
2025 Q4	–	Sell	-720,452	Closed	-$3.12M	–	98
2025 Q3	$3.12M	Buy	+720,452	New	+$1.3M	0.42%	55
2024 Q3	–	Sell	-328,504	Closed	-$1.15M	–	83
2024 Q2	$1.15M	Hold	328,504	–	–	0.27%	55
2024 Q1	$844K	Sell	328,504 -134,493	-29%	-$477K	0.23%	61
2023 Q4	$2.16M	Buy	462,997 +58,957	+15%	+$295K	0.64%	46
2023 Q3	$2.67M	Buy	404,040 +244,040	+153%	+$1.63M	0.81%	41
2023 Q2	$1.31M	Buy	+160,000	New	+$1.29M	0.41%	53

Other funds holding ZURA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Silverarc Capital Management's ZURA Position: Q2 2026 in Review

Silverarc Capital Management sold out of Zura Bio (ZURA) in Q2 2026, closing a stake of 560,651 shares — an estimated $3.34M sold.

Silverarc Capital Management first reported a position in ZURA in Q2 2023 and held it in 7 quarters. The position peaked at $3.34M in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

Silverarc Capital Management reported no remaining Zura Bio position as of Q2 2026 after selling out during the quarter.
Silverarc Capital Management sold 560,651 Zura Bio shares in Q2 2026, an estimated $3.34M.
Silverarc Capital Management first reported a position in Zura Bio in Q2 2023 and held it in 7 quarters.
Silverarc Capital Management's Zura Bio position peaked at $3.34M in Q1 2026.
95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Silverarc Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.